Podcasts about Symposium

Fr. Robert McTeigue continues with his critique of the inconsistent consistory, this time focusing on remarks from Cardinal Fernández about preaching and intellectual humility. Father finishes with Weekend Readiness to prepare you for Sunday Mass. Show Notes “Do Not Ask the Light, but the Fire”. Opening Meditation of the Plenary Session of the Dicastery for the Doctrine of the Faith (27 January 2026)  Fides et Ratio (14 September 1998) Veritatis Splendor (6 August 1993) Pascendi Dominici Gregis (September 8, 1907) Symposium on the Greatest Threats to the Church | New Oxford Review  Étienne Gilson – The Intelligence in the Service of Christ the King (1937)  St. Bonaventure's on the Reduction of the Arts to Theology  Fourth Sunday in Ordinary Time | USCCB  Sacred Heart Catholic School to learn trade skills from local masters First woman to lead Church of England confirmed in ceremony  German Cardinal: ‘For Me the Synodal Way Is Over'| National Catholic Register Old church in Duquesne now home to retro-style arcade - CBS Pittsburgh  Fr. Robert McTeigue's Sermon on St. Thomas Aquinas iCatholic Mobile The Station of the Cross Merchandise - Use Coupon Code 14STATIONS for 10% off | Catholic to the Max Read Fr. McTeigue's Written Works! "Let's Take A Closer Look" with Fr. Robert McTeigue, S.J. | Full Series Playlist Listen to Fr. McTeigue's Preaching! | Herald of the Gospel Sermons Podcast on Spotify Visit Fr. McTeigue's Website | Herald of the Gospel Questions? Comments? Feedback? Ask Father!

Steve Gross, Honore Comfort & Mark Barden Wine Institute Monterey, Calif. — Sitting down with Steve Gross has become one of our favorite DTC Wine Symposium traditions. Not only does he have one of the best radio voices in the wine business, but he's spent nearly four decades on the front lines of wine shipping battles nationwide. Largely thanks to his efforts, residents of 49 states can now receive direct-to-consumer wine shipments. Steve is always ready to update us on the latest state-level shenanigans aimed at limiting consumer access to their favorite wines. But his role has recently grown even bigger. Last month, he stepped into the role of interim president of the Wine Institute. Frankly, we couldn't feel more confident having Steve Gross leading this crucial organization at such a pivotal moment. One of the big-picture initiatives coming out of the Wine Institute is the Share Wine Co-Lab. To dig into how and why it came together, we were joined by a familiar face for Sonoma County folks, Honore Comfort, Vice President of International Marketing at the Wine Institute, along with marketing consultant Mark Barden. Together, we unpacked the market research that led to the creation of Share Wine Co-Lab, and explored how wineries of all sizes, in any region, can use it to better promote themselves, their communities, and wine in general. Sit down, pop a bottle, and get ready to go deep into the wine business. The dispatches from DTC Wine Symposium 2026 are just getting started. [Ep 398] Learn more: https://dtcwinesymposium.com/ https://freethegrapes.org/ https://wineinstitute.org/news/share-wine-colab/

In a world of constant noise, endless distraction, and performative busyness, what does it mean to pursue true excellence? Not hustle-for-hustle's-sake kind—but the kind rooted in values, meaning, and sustainable high performance. Today's guest is one of the clearest voices on that question: Brad Stulberg—bestselling author, performance coach, and researcher on sustainable excellence. Brad is a rare returning guest to The Coaching Lab for good reason. His work regularly appears in the New York Times, Wall Street Journal, and The Atlantic, and he serves on faculty at the University of Michigan. His new book, The Way of Excellence, reframes excellence not as a finish line—but as a process of mastery, meaning, and becoming. Drawing on modern science, timeless philosophy, and real-world stories of elite performers, Brad shows us how to integrate mastery and mattering—so we can perform at our best without burning out or losing what truly matters. In this conversation, we explore:·       Why excellence is not about outcomes—but about process·       How to build real confidence through consistency·       The difference between “pseudo-excellence” and the real thing·       How focus, discipline, and values alignment create sustained performance·       And how to pursue greatness without sacrificing well-being, relationships, or meaningWhether you're an athlete, coach, leader, entrepreneur, or simply someone who wants to live with greater intention, this episode delivers a clear, grounded roadmap for what it really means to be at your best—day after day.Info re earning your health & wellness coaching certification, annual Rocky Mountain Coaching Retreat & Symposium & more via https://www.catalystcoachinginstitute.com/ Best-in-class coaching for Employers, EAPs & wellness providers https://catalystcoaching360.com/ Tap into the home of the (freely available) Not Done Yet! articles on unlocking life's 2nd half here. YouTube Coaching Channel https://www.youtube.com/c/CoachingChannel Contact us: Results@CatalystCoaching360.comTwitter: @Catalyst2ThriveWebsite: CatalystCoaching360.comIf you are a current or future health & wellness coach, please check out our Health & Wellness Coaching Community on Facebook: https://www.facebook.com/groups/278207545599218. This is a wonderful group if you are looking for encouragement, ideas, resources and more.

Mentioned in this EpisodeConnect with the Podcast: Facebook: @texaswinepod Instagram: @texaswinepod Email: texaswinepod@gmail.com Show notes and more: www.thisistexaswine.com Help the Show: Subscribe to the newsletter. Donate virtual Texas wine or join the podcast membership at the Gold Medal, Silver Medal, or Bronze Medal Level! Leave a review on Spotify or Apple Podcasts! Thanks to our sponsor Bending Branch Winery. Contact Jen at bendingbranchwinery.com for all of your custom crush winemaking needs!Mentioned in this EpisodeTexas Hill Country Wine Industry Awards2025 Winners from TopTexasWines.comTexas Results from San Francisco Chronicle Wine CompetitionWilliam Chris Vineyards' Enchante makes Decanter List of Top 50 Wines in the US for 2025- paywallNew Tasting Rooms for Jaclynn Renee Wines (Wimberly) and Nobleman Wines (Glen Rose)Hill Country Wine Symposium Closing Panel Panelists: Ron Yates, Ron Yates Wines and Spicewood Vineyards Katy Jane Seaton, Farmhouse Vineyards Jennifer Beckmann, Rerooted 210 Chris Brundrett, William Chris Wine Co. Roxanne Meyers, Lost Oak Winery John Rivenburgh, Kerrville Hills Winery Demerit and Gold Star DEMERIT:none this episode GOLD STARS: none this episode Special ThanksNeed lodging in Fredericksburg? Check out Cork + Cactus! Find Cork + Cactus and many more great rentals at Heavenly Hosts.com! Thanks to Texas Wine Lover for promotional help! For the latest information on Texas wineries and vineyards, visit Texas Wine Lover. Don't forget to download the Texas Wine Lover app too!Podcast music is by Landon Lloyd Miller. Check him out on Spotify HERE

Today, we're bringing you two live recordings from last year's European Coffee Symposium, featuring conversations with Joe & The Juice and Hagen. While both are Danish-inspired concepts, each offers a distinct perspective on growth and the customer experience.Thomas Nørøxe, CEO of Joe & The Juice, shares how the business has built a high-performance culture rooted in energy, ambition and personal development. He also explains how innovation across the brand is guided by four core pillars: health, experience, convenience and sustainability.Tim Schroeder, CEO and Founder of boutique specialty coffee chain Hagen, shares his philosophy of building an analogue brand in a digital world and why he prioritises human connection and in-store experiences over a reliance on digital technology.Credits music: "Heather" by Ayngi in association with The Coffee Music Project and SEB Collective. Tune into the 5THWAVE Playlist on Spotify for more music from the showSign up for our newsletter to receive the latest coffee news at worldcoffeeportal.comSubscribe to 5THWAVE on Instagram @5thWaveCoffee and tell us what topics you'd like to hear

Featuring perspectives from Dr Angela DeMichele, Dr Komal Jhaveri, Dr Erica Mayer, Dr Hope S Rugo and Dr Seth Wander, including the following topics:  Introduction (0:00) 1985 NCI Consensus Conference on Early Breast Cancer: Sir Richard Peto, FRS (2:01) Current Role of Genomic Assays in Treatment Decision-Making for Localized Hormone Receptor (HR)-Positive Breast Cancer — Dr DeMichele (5:13) Case: A premenopausal woman in her mid 40s with an ER-positive, HER2-negative, node-negative infiltrating ductal carcinoma (IDC) after partial mastectomy/radiation therapy who enrolls in the prospective, observational FLEX study: MammaPrint® low risk — Laurie Matt-Amaral, MD, MPH (15:30) Case: A premenopausal woman in her mid 40s after modified radical mastectomy for T2N0 ER-positive, HER2-negative IDC with an Oncotype DX® Recurrence Score (RS®) of 19 — Swati Vishwanathan, MD Case: A woman in her mid 60s with locally advanced (19 cm) ER-positive, HER2-low (IHC 1+) Stage IIIB mucinous carcinoma breast cancer and an RS of 18 — Alan B Astrow, MD (22:40) Role of CDK4/6 Inhibitors and Other Novel Strategies in Therapy for HR-Positive, HER2-Negative Localized Breast Cancer — Dr Jhaveri (30:18) Case: A woman in her mid 50s with ER-positive, HER2-negative Stage IIB, T2N1 IDC after neoadjuvant dose-dense AC-T, lumpectomy and adjuvant radiation therapy — Eleonora Teplinsky, MD (42:14) Case: A woman in her mid 60s with ER-positive, HER2-negative breast cancer with a surgically removed solitary lung metastasis after 4 years of adjuvant letrozole — Eric Fox, DO (46:32) Evolving Up-Front Treatment Paradigm for HR-Positive, HER2-Negative Metastatic Breast Cancer (mBC) — Dr Rugo (49:45) Case: A woman in her early 80s with Type 2 diabetes, well controlled hypertension and recurrent ER-positive, HER2-negative mBC after 4 years of adjuvant letrozole — Sunil Gandhi, MD (1:02:30) Clinical Utility of Agents Targeting the PI3K/AKT/mTOR Pathway for Patients with Progressive HR-Positive mBC — Dr Mayer (1:06:37) Case: A woman in her late 60s with ER-positive, HER2-low (IHC 1+), PIK3CA-mutant mBC with disease progression after 2 years of adjuvant letrozole — Laila Agrawal, MD (1:20:22) Case: A woman in her early 60s with ER-positive, HER2-low PIK3CA-mutant mBC and disease progression on first-line palbociclib/fulvestrant — Dr Teplinsky (1:26:36) Results from the Global Phase III lidERA Breast Cancer Trial of Giredestrant versus Standard Endocrine Therapy as Adjuvant Treatment for ER-Positive, HER2-Negative Localized Breast Cancer (1:31:48) Current and Future Role of Oral Selective Estrogen Receptor Degraders for Progressive HR-Positive mBC — Dr Wander (1:42:30) Case: A woman in her early 100s with locally advanced ER-positive, HER2-negative breast cancer with disease progression on letrozole, now with an ESR1 mutation — Dr Astrow (1:57:51) CME information and select publications

Dr Angela DeMichele from the Abramson Cancer Center in Philadelphia, Pennsylvania, Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Seth Wander from Massachusetts General Hospital in Boston discuss real-world cases and recent clinical data surrounding the management of HR-positive breast cancer.CME information and select publications here.

Dr. Monty Pal and Dr. Mary Feng discuss the latest advances in metastatic colorectal, gastric, and gastroesophageal cancers that were presented at the 2026 ASCO Gastrointestinal Cancers Symposium.

In this episode of ⁠The Tarot Diagnosis⁠, I'm exploring something that's been stirring in me since a recent book club event inside The Symposium: the way we unconsciously project motherhood onto tarot's female figures. After an insightful conversation in the book club (shoutout to Darcy for naming it so clearly: “Tarot doesn't need another mother”), I couldn't stop thinking about how often cards like Strength, the Empress, and all four Queens get flattened into maternal archetypes.And of course, we're not just doing this in tarot. We're doing this everywhere, all the time. In this episode, I explore:Why the Strength card has become one of my least favorite cards (for now)How projection and cultural conditioning shape our interpretations of female-presenting figures in tarotThe dangers of turning all gentleness and emotional regulation into compulsory/female/motherly careWhat it might mean to view Strength as discernment, regulation, or even female rage instead of caretakingI also talk about the psychological cost of maternalizing every act of compassion and why it limits not only women, but all people across the gender spectrum who wish to express care, leadership, or emotional depth.This episode is part tarot analysis, part cultural critique, and part personal reflection on how we assign meaning to caretaking and why it matters.I close the episode by offering a question for your next reading:In what ways does this card validate me and in what ways does it confront me?Book Referenced: Talismans and TarotDeck used: Tarot Vintage

Part one of three. Johann Wolfgang von Goethe often spoke of a dangerous but invigorating life-force that he christened "the daemonic". In his conversations with Eckermann, and in his autobiography Dichtung und Wahrheit, he describes the daemonic by direct reference to Spinoza, and his pantheist philosophy. In this first episode of our series on Goethe's Daemonic, we're going to look at Goethe's statement of the idea, then go back in time to consider: Plato's Symposium, the daemonion of Socrates, the writings of Philo of Alexandria, Justin Martyr and St. Augustine, and finally, the alleged Spinozism of the playwright Gotthold Lessing and the "pantheism controversy" that emerged over Lessing's legacy, argued by Friedrich Heinrich Jacobi and Moses Mendelssohn.Next week (part two) will involve a closer reading of Goethe's concept of the daemonic and the influence of Herder on Goethe's reception of Spinoza. Episode art: Lessing, pictured in front of some Greek daimones.

In this episode, host Walt Bleser sits down with Jared Hopewell, AVP, Communications & Signals at Norfolk Southern, and Jason Schrader, Assistant Chief Engineer at CSX, to introduce what attendees can expect at the Communications, Signals & Information Technology (CS&IT) Symposium in Jacksonville, FL, March 3–5. The event will feature immersive field trips and presentations that cover the past, present, and future of the industry. If you're involved in rail technology or curious about where the industry is headed, this Symposium is the place to be. They also discuss the collaborative efforts of CS&IT Committees to advance safety signaling, an industry-wide initiative. Key topics include Positive Train Control and the growing role of AI in inspections, efficiency, and day-to-day operations. This is just a preview. Listen now to hear the full story behind the people and ideas driving these innovations and get all the details you need to join the conversation at the Symposium.

As Emerging Civil War prepares to examine "Partnerships & Rivalries" at our 2026 Symposium, we take a look at one of the most important relationships to Union Lt. Gen. Ulysses S. Grant. Curt Fields and Melissa Winn join ECW Podcast host Chris Mackowski to talk about Grant's relationship with his chief of staff, John Rawlins.  This episode of the Emerging Civil War Podcast is brought to you by Civil War Trails, the world's largest open-air museum, offering more than 1,500 sites across six states. Request a brochure at ⁠⁠⁠⁠civilwartrails.org⁠⁠⁠⁠ to start planning your trip today.

One of the most common questions among both new and established coaches is how to establish your pricing. In this episode, Leigh, Suzy and Brad provide a round-table discussion on a range of pricing-related topics ranging from how the market affects your pricing to how to land on "your" number, the role of packages and much more.Info re earning your health & wellness coaching certification, annual Rocky Mountain Coaching Retreat & Symposium & more via https://www.catalystcoachinginstitute.com/ Best-in-class coaching for Employers, EAPs & wellness providers https://catalystcoaching360.com/ Tap into the home of the (freely available) Not Done Yet! articles on unlocking life's 2nd half here. YouTube Coaching Channel https://www.youtube.com/c/CoachingChannel Contact us: Results@CatalystCoaching360.comTwitter: @Catalyst2ThriveWebsite: CatalystCoaching360.comIf you are a current or future health & wellness coach, please check out our Health & Wellness Coaching Community on Facebook: https://www.facebook.com/groups/278207545599218. This is a wonderful group if you are looking for encouragement, ideas, resources and more.

In episode 236 Elissa Farrow returns to the Pod, and brings some friends, to talk about the second iteration of the Oceania Futures and Foresight Symposium on the 26th and 27th of March

Texas A&M University adopted a rule last November banning the teaching of “race and gender ideology,” which includes Plato's 2,400-year-old “Symposium.” Professor Martin Peterson explains how he thinks the move will hurt his philosophy students.Then, Bob Weir, a founding member of and guitarist for the Grateful Dead, died this month. Music journalist Alan Paul unpacks Weir's rhythm guitar playing style and how it defined rock & roll music.And, in California, three people have died, and dozens more are sick after eating death cap mushrooms. Interim health officer for Sonoma County, Dr. Michael Stacey, explains more.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

This week Bryan is live from his office where he's been purging pandemic kitchen purchases. Erin does some Groceries-style recommendations including Southwest Airlines' hottest flight snack and the fudge to dip them in. Erin discusses Texas A&M University's decision to remove Plato's Symposium from philosophy professor Martin Peterson's curriculum due to a new policy enacted in the fall that prohibits advocating "race or gender ideology, or topics related to sexual orientation or gender identity”. Bryan discusses the murder of Renee Good by ICE, and resources of where we can donate to causes or organizations that can benefit those in need in our own communities. For this week's Heated Rivalry Recap visit www.patreon.com/attitudesSee omnystudio.com/listener for privacy information.

When Dave Feldman first walked into a LowCarbUSA® event in 2016 carrying a laptop full of lab results, few people could have predicted where that moment would lead.  "I'm approaching everyone with my computer," Feldman recalls, "because I'm doing these self-experiments—getting blood work—and I'm trying to figure out why my cholesterol numbers were doing what they were doing."  What started as a personal puzzle became The Cholesterol Code, a global research effort, a nonprofit scientific foundation, and now a forthcoming documentary film. In this episode of the LowCarbUSA Podcast, host Doug Reynolds sits down with Feldman to trace that journey—and to explain why the next chapter will take center stage at the Symposium for Metabolic Health in Boca Raton, January 23–25, 2026 The Question That Wouldn't Go Away Dave's original question was deceptively simple: Why do some metabolically healthy, lean people see their LDL cholesterol rise dramatically on a ketogenic diet?  Over time, he noticed a consistent pattern. These individuals didn't just have high LDL—they also tended to have high HDL, low triglycerides, and excellent metabolic health. In 2017, he coined a name for this group: Lean Mass Hyper-Responders (LMHRs). But identifying a pattern wasn't enough.  "Even if the lipid energy model proves correct," Dave explains, "does that mean having higher LDL on a ketogenic diet carries higher cardiovascular risk?"  Answering that question required something far more difficult than a blog post or a hypothesis: a prospective imaging study. Building a Study When No One Will Fund One Dave spent years trying—and failing—to convince established institutions to study this population.  "There's not a lot of funding to study metabolically healthy people with sky-high LDL," he says dryly. "The interest is usually in people who already have multiple cardiovascular risk factors—which confounds everything."  So in 2019, he made a radical decision. He founded the Citizen Science Foundation, a public charity created for a single purpose: to fund independent research, with no money going to salaries or overhead.  "We raised $200,000,"Dave says, "and paid a research center to do the study."  By late 2021, recruitment was underway. One hundred lean, metabolically healthy ketogenic individuals underwent coronary CT angiography (CTA) scans to assess plaque in their coronary arteries, with follow-up scans roughly one year later. What the Data Actually Showed The early findings were striking.  When Dave's cohort was matched against participants from the Miami Heart Study, there was no statistically significant difference in coronary plaque, despite Dave's group having LDL levels less than twice as high.  "In fact," he notes, "our group trended toward lower plaque." But the most important finding emerged as more analyses were completed:  "There was no association between ApoB or LDL and plaque progression," Dave says. "Whatever your LDL level was, it did not correspond with how plaque developed."  What did matter? Baseline plaque. "Whether you're low-carb or not," he explains, "the more plaque you have at baseline, the more likely you are to see progression. That's consistent with the existing literature." When One Dataset Didn't Make Sense Then came the controversy.  An AI-based quantitative analysis from a company called Cleerly showed plaque progression that appeared inconsistent—not only with Dave's other data, but with decades of prior research.  "All of the scans showed progression," he says. "No regression. Not even noise."  For an engineer, that raised immediate red flags.  "If a bathroom scale is off by a quarter pound," Dave explains, "you expect wobble.  Below the noise floor, measurements go up and down.  But this dataset showed only one direction." Later, when Dave gained access to the anonymized data, he identified multiple anomalies and requested a blinded quality-control reanalysis.  That request was declined.  "I don't assume wrongdoing," he emphasizes. "But when something looks implausible, the response should be course correction."  Instead, he sought independent confirmation.  A second AI company, HeartFlow, conducted a fully blinded analysis—and its results aligned with every other analysis except Cleerly's.  "Three out of four analyses agree," he says. "Cleerly is the outlier." Why This Matters Beyond One Study The implications extend far beyond a single dataset.  Dave believes this episode exposes a deeper issue in nutrition and cardiovascular science: how dominant theories shape interpretation.  "The lipid hypothesis has a gravitational pull," he says. "It affects what people expect to see—and what they question."  As I put it, Dave has repeatedly taken the LowCarbUSA stage to announce findings that challenge assumptions—and each time, the conversation moves forward.  "If we want better answers," Dave says, "we have to do better science." The Documentary—and What Comes Next All of this has reshaped his upcoming documentary, The Cholesterol Code. Originally slated for release last year, the film has been expanded to include the scientific and human story behind these findings.  "We couldn't release it without covering what happened," he explains. "It's part of the truth."  For the first time anywhere, the official trailer for the film will be shown at the LowCarbUSA Symposium in Boca, immediately following Dave's talk.  Attendees will also be invited to help bring the film to live screenings around the world.  "The world premiere of the trailer will be at your conference," Dave told me.  "That alone is worth coming for." Why You'll Want to Be There One full day of the Boca symposium is dedicated to cardiovascular health, and Dave is one of the central voices shaping that conversation. Whether you attend in person or via live stream, this is a rare opportunity to engage directly with research that is still unfolding—and with the scientist who helped drive it. As Dave puts it: "The work just needs to get done,  and in Boca, it will." Learn more and reserve your in-person or virtual seat for the Boca Symposium for Metabolic Health (January 23–25, 2026)

Featuring perspectives from Prof Giuseppe Curigliano, Prof Nadia Harbeck, Dr Ian E Krop, Dr Nancy U Lin and Dr Joyce O'Shaughnessy, including the following topics:  Introduction (0:00) Considerations in the Care of Patients with Localized HER2-Positive Breast Cancer — Prof Harbeck (1:39) Case: A woman in her mid 50s presents with locally advanced ER-positive, HER2-positive breast cancer — Alan B Astrow, MD (12:52) Case: A woman in her mid 40s with ER-positive, HER2-positive Stage II breast cancer s/p neoadjuvant TCHP with residual disease receives adjuvant T-DM1 but discontinues due to neuropathy — Laila Agrawal, MD (20:02) Previously Untreated HER2-Positive Metastatic Breast Cancer (mBC) — Prof Curigliano (25:10) Case: A woman in her early 80s presents with de novo metastatic (bone-only) ER-positive, HER2-positive breast cancer — Zanetta S Lamar, MD (35:03) Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer — Dr Lin (46:20) Case: A woman in her early 60s with ER-positive, HER2-positive breast cancer develops a cerebellar metastasis while receiving adjuvant anastrozole after prior anti-HER2 therapy — Justin Favaro, MD, PhD (59:41) Case: A woman in her early 40s with ER-negative, HER2-positive mBC develops a headache shortly after neoadjuvant TCHP, surgery and postneoadjuvant T-DM1 and is found to have an isolated 4-cm brain metastasis — Dr Agrawal (1:05:36) Selection and Sequencing of Therapy for Relapsed/Refractory HER2-Positive mBC in the Absence of CNS Involvement — Dr Krop (1:12:00) Case: A woman in her early 40s with ER-positive, HER2-positive mBC receives THP (docetaxel/trastuzumab/pertuzumab) and maintenance tucatinib with trastuzumab/pertuzumab on a clinical trial and now has disease progression — Yanjun Ma, MD, PhD (1:23:04) Tolerability Considerations with HER2-Targeted Therapies — Dr O'Shaughnessy (1:29:32) Case: A woman in her mid 60s presents with localized ER-negative, HER2-positive infiltrating ductal carcinoma — Erik Rupard, MD (1:46:06) Case: A woman in her early 70s with recurrent ER-positive, HER2-positive mBC receives trastuzumab deruxtecan (T-DXd) and has concerning pulmonary symptoms but without findings on diagnostic imaging — Kimberly Ku, MD Case: A woman in her mid 40s with ER-positive, HER2-positive breast cancer metastatic to the brain and lung who received multiple prior treatments responds to T-DXd but develops Grade 1 interstitial lung disease — Richard Zelkowitz, MD (1:49:49) CME information and select publications

In another of our special episodes recorded at the CEPR annual Symposium, we ask: is it time for Europe to rearm?The message from the US could not be clearer: it is time for European countries to take care of their own security. If Europe decides to rearm, it has the industrial base – but Moritz Schularick of the Kiel Institute and CEPR warns that it isn't converting that capacity into credible deterrence. Tim Phillips asks him what European rearmament could mean in practice: not just scaling up production but buying smarter and investing in next-generation technologies that can spill over into the wider economy. And is there enough political will to create a European defence architecture that can stand on its own?

Prof Giuseppe Curigliano from the University of Milan in Italy, Prof Nadia Harbeck from LMU University Hospital in Munich, Germany, Dr Ian E Krop from Yale Cancer Center, Dr Nancy U Lin from Dana-Farber Cancer Institute and Dr Joyce O'Shaughnessy from Baylor University Medical Center discuss real-world cases and recent clinical data pertinent to the management of HER2-positive breast cancer. CME information and select publications here.

Dr Nancy L Bartlett from the Washington University School of Medicine, Dr John P Leonard from the Perlmutter Cancer Center, Dr Matthew Matasar from Rutgers Cancer Institute, Dr Loretta J Nastoupil from Southwest Oncology and Prof Pier Luigi Zinzani from the University of Bologna in Italy discuss recent updates on available and novel treatment strategies for follicular lymphoma and diffuse large B-cell lymphoma. CME information and select publications here.

The cohosts of the Cavas Ships Podcast — Chris Cavas and Chris Servello — join Defense & Aerospace Report Editor Vago Muradian to discuss the capabilities Navy needs given the threats the United States faces, whether the proposed “Golden Fleet” and new Defiant-class battleship will add needed capability or drain resources from more important programs, whether the service has learned lessons from past failed programs to ensure that future efforts are successful, improving the Navy's maintained capabilities to get more out of the fleet it has, and what they're expect to hear at the Surface Navy Association's annual symposium in Arlington, Va. The Defense & Aerospace Report is an SNA media partner and our coverage at the symposium is sponsored by Lockheed Martin.

Steven F. Hayward, Pepperdine University professor, blogger at the "Political Questions" Substack, and host of the Three Whiskey Happy Hour Podcast, opens the show with Seth to talk about the need for a study of great works after a ban on teaching Plato at Texas A&M University, Plato’s Symposium, his recent piece, “Reagan, the Original MAGA President?” and more!See omnystudio.com/listener for privacy information.

Featuring perspectives from Prof Claire Harrison, Dr Andrew T Kuykendall, Dr Stephen T Oh, Dr Jeanne Palmer and Dr Raajit K Rampal, including the following topics:  Introduction (0:00) Current Clinical Decision-Making for Myelofibrosis (MF) in the Absence of Severe Cytopenias — Dr Palmer (1:46) Case: A woman in her mid 70s presents with symptomatic JAK2 V61F-mutant primary MF with mild anemia and normal platelet count — John Mascarenhas, MD (16:09) Discussion: Asymptomatic MF; re-reads of pathology reports; "triple-negative" MF; secondary causes — Laura C Michaelis, MD (22:47) Discussion: Ruxolitinib-associated dermatologic cancers and weight gain — Prithviraj Bose, MD (27:34) Managing MF in Patients with Anemia — Dr Oh (30:21) Case: A man in his early 70s with splenomegaly and mild fatigue is diagnosed with JAK2 V617F-mutant primary MF and receives momelotinib — Dr Michaelis (42:34) Discussion: Post-hoc analysis from the SIMPLIFY-1 trial — Dr Bose (46:20) Managing MF in Patients with Thrombocytopenia — Dr Rampal (49:57) Discussion: MF with moderate thrombocytopenia — Dr Michaelis Case: A man in his mid 60s with primary MF and anemia, thrombocytopenia and splenomegaly has a low JAK2 V617F allele frequency — Dr Mascarenhas (1:05:46) Promising Novel Agents Under Investigation for MF — Prof Harrison (1:11:21) Case: A woman in her late 70s with primary MF with CALR1 and SF3B1 mutations and anemia receives luspatercept — Dr Michaelis Discussion: Luspatercept for MF-associated anemia — Dr Bose (1:24:52) Discussion: Promising novel therapies — Dr Mascarenhas (1:28:24) Current and Future Management of Systemic Mastocytosis — Dr Kuykendall (1:32:40) Discussion: Initial assessment of patients diagnosed with systemic mastocytosis; avapritinib dosing — Dr Bose (1:49:12) Discussion: Systemic mastocytosis with associated hematologic neoplasm — Dr Bose (1:52:24) Discussion: Bezuclastinib for systemic mastocytosis — Dr Bose (1:55:23) CME information and select publications  

Prof Claire Harrison from Guy's and St Thomas' NHS Foundation Trust in London, Dr Andrew T Kuykendall from Moffitt Cancer Center, Dr Stephen T Oh from the Washington University School of Medicine, Dr Jeanne Palmer from the Mayo Clinic School of Medicine and Dr Raajit K Rampal from Memorial Sloan Kettering Cancer Center discuss recent updates on available and novel treatment strategies for myelofibrosis and systemic mastocytosis.CME information and select publications here.

This conversation explores U2FP's upcoming 20th Annual Science and Advocacy Symposium, reflecting on the past, present, and future of spinal cord injury research and advocacy. Jason and Matthew discuss the significance of this event, the importance of community engagement, and the need for legislative action to restore funding for spinal cord injury research. They describe some of the key speakers, sessions, and the unique opportunity for attendees to participate in advocacy efforts, starting with our in a Roll On The Capital happening on the last day of the conference. More info: https://u2fp.org/get-educated/curecast/episode-138.html

Featuring perspectives from Dr Javier Cortés, Dr Rita Nanda, Prof Peter Schmid and Dr Priyanka Sharma, including the following topics:  Introduction (0:00) Case: A woman in her early 80s with multiple comorbidities and triple-negative breast cancer (TNBC) develops bone-only metastases 4 months after declining capecitabine for post-neoadjuvant residual disease — Justin Favaro, MD, PhD (1:50) Case: A woman in her mid 70s with ER-negative, HER2-low (IHC 1+), PIK3CA-mutated, PD-L1-positive metastatic breast cancer (mBC) after receiving 3 cycles of neoadjuvant paclitaxel/carboplatin/pembrolizumab, which was discontinued — Alan Astrow, MD (6:47) Previously Untreated Metastatic TNBC (mTNBC) — Prof Schmid (10:47)  Case: A woman in her early 80s with multiregimen-recurrent ER-positive, HER2-low (IHC 1+) ESR1-mutant mBC receives sacituzumab govitecan — Jennifer Yannucci, MD (27:19) Case: The role of datopotamab deruxtecan (Dato-DXd) for patients with ER-positive, HER2-low mBC who experienced disease progression on prior trastuzumab deruxtecan (T-DXd) — Ranju Gupta, MD; Case: A woman in her late 70s with bilateral recurrence in the lungs of ER-negative, HER2-low (IHC 1+) breast cancer (PD-L1 TPS 20%) receives Dato-DXd with durvalumab on protocol — Yanjun Ma, MD, PhD (31:35) Integrating Antibody-Drug Conjugates (ADCs) into the Management of Endocrine-Resistant Hormone Receptor-Positive mBC — Dr Sharma (36:31) Case: A woman in her early 70s with recurrent ER-negative, HER2-low (IHC 2+) mBC receives sacituzumab govitecan and achieves complete remission — Dr Gupta; Case: Management of neutropenia associated with sacituzumab govitecan — Gigi Chen, MD (50:30) Case: A woman in her late 60s with recurrent ER-negative, HER2-low (IHC 1+) mBC (HER2 V69L mutation) receives T-DXd and achieves a complete response but develops Grade 1 interstitial lung disease — Dr Gupta; Case: Management of T-DXd-related side effects — Laila Agrawal, MD (54:10) Selection and Sequencing of Therapy for Relapsed/Refractory mTNBC — Dr Nanda (58:59) Case: A woman in her early 40s with multiregimen-recurrent ER-positive, HER2-low mBC who has experienced severe nausea with past treatments is about to initiate T-DXd — Atif M Hussein, MD, MMM (1:12:40) Tolerability and Other Practical Considerations with ADCs and Other Cytotoxic Agents for mBC — Dr Cortés (1:18:10) CME information and select publications

Dr Javier Cortés from the International Breast Cancer Center in Barcelona, Spain, Dr Rita Nanda from the University of Chicago, Prof Peter Schmid from Barts Cancer Institute in London, United Kingdom, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood discuss key clinical data with antibody-drug conjugates for metastatic breast cancer and their expert perspectives surrounding its clinical applications.CME information and select publications here.

Featuring perspectives from Dr Matthew S Davids, Dr Bita Fakhri, Prof Constantine Tam and Dr Jennifer Woyach, including the following topics:  Introduction (0:00) Current and Emerging Approaches to First-Line Therapy for Chronic Lymphocytic Leukemia (CLL) — Dr Davids (1:42) Case: A man in his mid 70s with a plethora of comorbidities but good performance status requires treatment for CLL — Bhavana (Tina) Bhatnagar, DO (14:58) Case: A man in his early 50s, a Jehovah's Witness, under observation for IGHV-mutated CLL develops pulmonary emboli and worsening lymphadenopathy, undergoes anticoagulation and begins therapy with zanubrutinib — Jennifer Yannucci, MD Case: A man in his mid 70s with a history of atrial fibrillation on apixaban receives zanubrutinib — Zanetta S Lamar, MD (22:30) Optimal Management of Adverse Events with Bruton Tyrosine Kinase and Bcl-2 Inhibitors; Considerations for Special Patient Populations — Prof Tam (32:50) Case: A man in his mid 90s with CLL has concurrent locally advanced Merkel cell carcinoma of the scalp — Erik Rupard, MD (50:51) Case: A woman in her early 50s under observation for IGHV-unmutated CLL develops progressive splenomegaly and receives obinutuzumab/venetoclax — Sean Warsch, MD (54:28) Selection and Sequencing of Therapy for Relapsed/Refractory CLL — Dr Woyach (1:05:51) Case: A man in his mid 70s with high-risk (del[TP53]) CLL experiences disease progression on ibrutinib and then venetoclax/obinutuzumab — Dr Bhatnagar (1:27:23) Case: A man in his early 80s with IGHV-unmutated CLL who previously received FCR now experiences disease relapse after 5 years of acalabrutinib, and a BTK C481S resistance mutation is detected — Priya Rudolph, MD, PhD (1:29:34) Chimeric Antigen Receptor T-Cell Therapy and Other Novel Strategies for CLL — Dr Fakhri (1:34:08) Case: A man in his early 70s with multiregimen-relapsed CLL experiences an 18-month response to pirtobrutinib — Brian P Mulherin, MD (1:50:46) CME information and select publications

Dr Matthew S Davids from Dana-Farber Cancer Institute, Dr Bita Fakhri from Stanford University School of Medicine, Prof Constantine Tam from Alfred Health in Melbourne, Australia, and Dr Jennifer Woyach from The Ohio State University Comprehensive Cancer Center review the treatment landscape for patients with chronic lymphocytic leukemia and discuss current research immediately before the 67th ASH Annual Meeting.CME information and select publications here.

We preview next week's 4th annual Arts Symposium at Carthage College. This year's event is titled "Borderlands and Crossroads: A Confluence of Art, Music, Film, and Everyday Life." This symposium, like its predecessors, celebrates the Samuel and Berry Schoen Collection of Soviet Art at Carthage. The event- which is free and open to the public- occurs January 13, 14 and 15. We speak with four members of the Carthage art faculty .... Leslie Brothers, Joshua McGowan, Lisa Bigalke, and Robin Holmes- as well as with current Carthage student Jared Werner- who are all participants in the symposium in one way or another. A selection of paintings from the Schoen Collection are already on display in the Johnson Arts Gallery. That exhibition is titled "Harvesting Light: Soviet Women in Labor and Life."

In the Real Science Exchange Legacy Series, we celebrate the pioneers who have shaped the dairy industry. In this episode, we honor Dr. Don Beitz, a distinguished professor at Iowa State University. At the 2025 ADSA Annual Meeting, a symposium was held titled “Donald C. Beitz Recognition Symposium: 50-Plus Years of Dairy Science Research.” The guests on this episode, all former graduate students of Dr. Beitz, were speakers at the event. Join us as we explore Dr. Beitz's contributions and enduring impact on our industry. Panelists introduce themselves and how they met Dr. Beitz. Tricky MS and PhD exam questions are also shared. Panelists emphasize Dr. Beitz's love for biochemistry, teaching, and collaboration. (1:17)Dr. Beitz shares about his early life, academic career, and family. (11:45)Dr. Goff's symposium presentation focused on Dr. Beitz and colleagues' contribution to our understanding of transition cow hypocalcemia. He talks about studies on low calcium diets, investigating the metabolic pathways of vitamin D, and low phosphorus diets. Dr. Beitz also studied the impact of vitamin D on meat tenderness. (22:37)Dr. Nelson's presentation detailed the advances in understanding bovine immunology from the work of Don Beitz and his colleagues. From the milk fever vitamin D research, it was also discovered that vitamin D had an impact on the immune system, which led to further work with vitamin A and immunity as well. Dr. Beitz also had students investigate calf growth rate influence on immune system development as well as Johne's disease. (27:22)Dr. Drackley focused on Dr. Beitz's work in understanding fatty liver and ketosis. The transition period was of interest to Dr. Beitz, which is reflected not only in his work in hypocalcemia, but also the lipid and carbohydrate metabolism of ketosis. Dr. Beitz and his colleague, Dr. Young, developed a successful ketosis model using a slight feed restriction and supplementing a ketone body precursor, which was used to investigate ketosis and fatty liver. (30:25)Dr. VandeHaar spoke about Dr. Beitz's passion for research and teaching in dairy science, biochemistry, and life. He emphasized the depth and breadth of Dr. Beitz's work and teaching. He shared that Dr. Beitz has served as major professor for around 107 graduate students and has taught biochemistry to over 16,000 students. (35:02)The panelists share stories about Dr. Beitz's humility, care and support for students, and the many different professional societies he has been involved in over his career. (38:39)Panelists share their take-home thoughts. (42:56)Please subscribe and share with your industry friends to invite more people to join us at the Real Science Exchange virtual pub table.  If you want one of our Real Science Exchange t-shirts, screenshot your rating, review, or subscription, and email a picture to anh.marketing@balchem.com. Include your size and mailing address, and we'll mail you a shirt.

What is a clear, personal vision? How does it overlap (or influence) goals? Why does it matter? What are the steps to discovering and clarifying a vision? What does this have to do with my life? Why not just set goals or resolutions?In this special bonus episode, Dr. Cooper shares a range of insights and "how-to's" related to the powerful, life-shifting step of clarifying and creating a clear personal vision!Accompanying notes utilized for this special episode, including examples, are available here.Info re earning your health & wellness coaching certification, annual Rocky Mountain Coaching Retreat & Symposium & more via https://www.catalystcoachinginstitute.com/ Best-in-class coaching for Employers, EAPs & wellness providers https://catalystcoaching360.com/ Tap into the home of the (freely available) Not Done Yet! articles on unlocking life's 2nd half here. YouTube Coaching Channel https://www.youtube.com/c/CoachingChannel Contact us: Results@CatalystCoaching360.comTwitter: @Catalyst2ThriveWebsite: CatalystCoaching360.comIf you are a current or future health & wellness coach, please check out our Health & Wellness Coaching Community on Facebook: https://www.facebook.com/groups/278207545599218. This is a wonderful group if you are looking for encouragement, ideas, resources and more.

Featuring perspectives from Dr Harry Paul Erba, Dr Amir Fathi, Dr Tara L Lin, Dr Alexander Perl and Dr Eytan M Stein, including the following topics:  Introduction (0:00) Up-Front Therapy for Older Patients with Acute Myeloid Leukemia (AML) — Dr Lin (1:46) Selection of Therapy for Younger Patients with AML without a Targetable Mutation; Promising Investigational Strategies — Dr Perl (25:38) Role of FLT3 Inhibitors in AML Management — Dr Erba (48:27) Incorporation of IDH Inhibitors into the Care of Patients with AML — Dr Fathi (1:10:28) Current and Future Role of Menin Inhibitors in the Treatment of AML — Dr Stein (1:37:29) CME information and select publications

Dr Harry Paul Erba from the Duke Cancer Institute, Dr Amir Fathi from Massachusetts General Hospital, Dr Tara L Lin from The University of Kansas Medical Center, Dr Alexander Perl from the University of Pennsylvania's Abramson Cancer Center and Dr Eytan M Stein from Memorial Sloan Kettering Cancer Center discuss recent data surrounding the management of AML and their perspectives on clinical application.CME information and select publications here.

In this episode of Sailing and Cruising the East Coast, host Bela Musits sits down with Roy Greenwald, an experienced offshore sailor who has completed multiple ocean crossings and long-distance races. Roy shares insights from his years at sea aboard his Valiant 42, a boat known more for blue-water cruising than high-performance racing—yet one that's carried him to impressive victories.Roy talks about competing in legendary events like the Newport to Bermuda Race and the Marion to Bermuda Race, where he and his wife even took first place. Bela and Roy explore what it takes to prepare both mentally and technically for ocean passages, how double-handed sailing challenges crews in unique ways, and why safety, seamanship, and teamwork matter most offshore.Beyond racing, Roy discusses his work organizing the Northeast Ocean Race Symposium, a one-day event that brings together sailors to learn about everything from race strategy and weather routing to offshore safety and boat preparation. It's a can't-miss gathering for anyone serious about long-distance cruising or competitive sailing along the U.S. East Coast.Whether you're planning your first offshore passage or dreaming of Bermuda, this episode offers inspiration, real-world lessons, and a deep dive into the spirit of adventure that defines ocean racing.⛵ Keywords: sailing podcast, offshore racing, Roy Greenwald, Valiant 42, Newport to Bermuda Race, Marion to Bermuda Race, ocean crossings, Northeast Ocean Race Symposium, cruising, East Coast sailing.To learn more about the Northeast Ocean Racing Symposium:https://marionbermuda.com/NORS/Connect With Us:If you enjoyed this episode, please subscribe and leave a review—it helps us reach more sailing enthusiasts like you!  Send us your comments and suggestions. sailingtheeast@gmail.comHappy Sailing!Bela and Mike

Ob der Druck zu Aufrüstung und Verteidigung eine neue europäische Identität erforderlich machen, diskutieren der Publizist Karl-Markus Gauß, der Journalist Misha Glenny, die Ex-Außenministerin Ursula Plassnik und der ORF-Journalist Gerald Heidegger unter Moderation Michael Kerbler, beim Symposium der Salzburger Festspiele, Teil 5. Hosted on Acast. See acast.com/privacy for more information.

In this episode of "From Busy to Rich," hosts Wes Young and Justin Lakin welcome Steve D'Annunzio, founder of the Soul Purpose Institute. They explore personal development and leadership through the lens of soul archetypes, emphasizing the importance of understanding one's strengths and weaknesses. Steve outlines five leadership levels, the role of spiritual awareness, and the value of stewardship. Listeners are also invited to access free resources from Steve's institute. In today's episode we will cover: Understanding unique strengths and weaknesses through archetypes Leadership levels and their significance in personal growth The importance of spiritual awareness and stewardship Strategies for financial advisors and business owners to enhance leadership The impact of diverse strengths within teams on achieving goals Resources: Submit your podcast question here! Transform your practice! Click Here to Access Your Free Mindscan! Sign up for the Symposium now! Learn more about Steve's work at Soul Purpose Institute! Other Listening Platforms: Listen on Apple Podcasts Stream on Spotify Watch on YouTube Connect with Us: Instagram X Facebook LinkedIn Youtube Wes Young Live Website

Wie Österreichs EU-Beitritt mit den demokratischen Revolutionen von 1989 zusammenhängt und wie die Umwälzungen von damals Europa bis heute prägen. Es diskutieren der Schriftsteller Karl-Markus Gauß, der Journalist Misha Glenny, Außenministerin a.D. Ursula Plassnik und ORF-Journalist Gerald Heidegger, moderiert von Michael Kerbler beim Symposium der Salzburger Festspiele 2025, Teil 4. Hosted on Acast. See acast.com/privacy for more information.

In this episode, we review papers that stood out to each of us from the 2025 Wild Turkey Symposium.   Resources:   Collier, B. A., & Chamberlain, M. J. (2025). The Notorious PIG: wild pigs are not primary predators of wild turkey nests. Wildlife Society Bulletin, e1618.   Danks, Z. D., et al. (2025). A national standardized wild turkey brood survey: The first 6 years. Wildlife Society Bulletin, e164   Moscicki, D. J., et al. (2025). Multi‐scale evaluation of eastern wild turkey nest‐site selection and nest survival. Wildlife Society Bulletin, e1635.   Ogawa, R., et al. (2025). Is wild turkey habitat selection spatially consistent? A three‐decade meta‐analysis in Mississippi. Wildlife Society Bulletin, e70000.   The Wildlife Society Bulletin - Wild Turkey Symposium   Thogmartin, W. E. (2001). Home-range size and habitat selection of female wild turkeys (Meleagris gallopavo) in Arkansas. The American Midland Naturalist, 145(2), 247-260.   Ulrey, E. E., et al. (2025). Use of LiDAR to examine habitat selection by incubating female wild turkeys in South Carolina. Wildlife Society Bulletin, e1628.   What does wild turkey nesting cover look like? (Video)   Our lab is primarily funded by donations. If you would like to help support our work, please donate here: http://UFgive.to/UFGameLab   Coming Soon: Wild Turkey Manager: Biology, History, & Heritage! Our newest online wild turkey training is launching soon! Be the first to know when our new course launches by signing up here!   Be sure to check out our comprehensive online wild turkey course featuring experts across multiple institutions that specialize in habitat management and population management for wild turkeys. Earn up to 20.5 CFE hours! Enroll Now!    Dr. Marcus Lashley @DrDisturbance, Publications Dr. Will Gulsby @dr_will_gulsby, Publications Turkeys for Tomorrow @turkeysfortomorrow  UF Game Lab @ufgamelab, YouTube   Want to help wild turkey conservation? Please take our quick survey to take part in our research!   Do you have a topic you'd like us to cover? Leave us a review or send us an email at wildturkeyscience@gmail.com!   Watch these podcasts on YouTube   Please help us by taking our (quick) listener survey - Thank you!    Check out the DrDisturbance YouTube channel! DrDisturbance YouTube   Want to help support the podcast? Our friends at Grounded Brand have an option to donate directly to Wild Turkey Science at checkout. Thank you in advance for your support!   Leave a podcast rating for a chance to win free gear!   This podcast is made possible by Turkeys for Tomorrow, a grassroots organization dedicated to the wild turkey. To learn more about TFT, go to turkeysfortomorrow.org.    Music by Artlist.io Produced & edited by Charlotte Nowak  

In this episode, we review papers that stood out to each of us from the 2025 Wild Turkey Symposium.   Resources:   Collier, B. A., & Chamberlain, M. J. (2025). The Notorious PIG: wild pigs are not primary predators of wild turkey nests. Wildlife Society Bulletin, e1618.   Danks, Z. D., et al. (2025). A national standardized wild turkey brood survey: The first 6 years. Wildlife Society Bulletin, e164   Moscicki, D. J., et al. (2025). Multi‐scale evaluation of eastern wild turkey nest‐site selection and nest survival. Wildlife Society Bulletin, e1635.   Ogawa, R., et al. (2025). Is wild turkey habitat selection spatially consistent? A three‐decade meta‐analysis in Mississippi. Wildlife Society Bulletin, e70000.   The Wildlife Society Bulletin - Wild Turkey Symposium   Thogmartin, W. E. (2001). Home-range size and habitat selection of female wild turkeys (Meleagris gallopavo) in Arkansas. The American Midland Naturalist, 145(2), 247-260.   Ulrey, E. E., et al. (2025). Use of LiDAR to examine habitat selection by incubating female wild turkeys in South Carolina. Wildlife Society Bulletin, e1628.   What does wild turkey nesting cover look like? (Video)   Our lab is primarily funded by donations. If you would like to help support our work, please donate here: http://UFgive.to/UFGameLab   Coming Soon: Wild Turkey Manager: Biology, History, & Heritage! Our newest online wild turkey training is launching soon! Be the first to know when our new course launches by signing up here!   Be sure to check out our comprehensive online wild turkey course featuring experts across multiple institutions that specialize in habitat management and population management for wild turkeys. Earn up to 20.5 CFE hours! Enroll Now!    Dr. Marcus Lashley @DrDisturbance, Publications Dr. Will Gulsby @dr_will_gulsby, Publications Turkeys for Tomorrow @turkeysfortomorrow  UF Game Lab @ufgamelab, YouTube   Want to help wild turkey conservation? Please take our quick survey to take part in our research!   Do you have a topic you'd like us to cover? Leave us a review or send us an email at wildturkeyscience@gmail.com!   Watch these podcasts on YouTube   Please help us by taking our (quick) listener survey - Thank you!    Check out the DrDisturbance YouTube channel! DrDisturbance YouTube   Want to help support the podcast? Our friends at Grounded Brand have an option to donate directly to Wild Turkey Science at checkout. Thank you in advance for your support!   Leave a podcast rating for a chance to win free gear!   This podcast is made possible by Turkeys for Tomorrow, a grassroots organization dedicated to the wild turkey. To learn more about TFT, go to turkeysfortomorrow.org.    Music by Artlist.io Produced & edited by Charlotte Nowak  

Die Vorstellung von Österreich als Kulturnation entstand in Abgrenzung zu Deutschland und Deutschtum. Was war die Idee 1955 wert und was gilt sie heute? Darüber diskutieren die Schriftstellerin Maja Haderlap, Bundespräsident a.D. Heinz Fischer, der Historiker Oliver Rathkolb, der Bankmanager Andreas Treichl, die Kulturmanagerin Kathrin Zechner, moderiert von Tarek Leitner, beim Symposium der Salzburger Festspiele 2025, Teil 3. Hosted on Acast. See acast.com/privacy for more information.

Featuring:Aamir Ibrahim, Attorney at Quan Law Group Leigh Hawley, Counsel at FIFA World Cup 2026 Host: Landis Barber, Safran Law OfficesThe 2025 Fall Symposium brought sports industry leaders to London on November 6. In this episode, Aamir Ibrahim of Quan Law Group, Leigh Hawley, counsel at FIFA World Cup 2026, and Landis Barber take listeners inside the Symposium, sharing firsthand experiences and unpacking what they learned about sports across the globe.

80 Jahre nach der Befreiung Österreichs vom Nationalsozialismus und dem Wiederaufbau der Salzburger Festspiele in der Zweiten Republik befindet sich die Welt auch heute in einem krisenhaften Umbruch und steuert auf eine geopolitische Neuordnung zu. Im Gespräch mit Oliver Rathkolb blickt Heinz Fischer auf die Anfänge der Ersten Republik zurück, beim Symposium der Salzburger Festspiele 2025, Teil 2. Hosted on Acast. See acast.com/privacy for more information.

In Salzburg stellten die USA nach dem Sieg über Hitlerdeutschland die Besatzungsmacht. Die Kulturpolitik war den amerikanischen Befreiern im Westen Österreichs deutlich weniger wichtig, als den Sowjets in Wien.Wie der Umbruch schließlich doch passierte und was bis heute nachwirkt, diskutierten im Rahmen der Salzburger Festspiele bei einem Symposium besprochen eine prominente Runde mit Mavie Hörbiger, Helga Rabl-Stadler, Oliver Rathkolb, Ilija Trojanow, Danielle Spera und Aleida Assmann moderiert von Hannelore Veith. Hosted on Acast. See acast.com/privacy for more information.

In this episode of the Nifty Thrifty Dentists Podcast, Dr. Glenn Vo sits down with Joe Laith, Marketing & Education Manager at NeoBiotech to uncover why NeoBiotech is often called implant dentistry's best-kept secret. They break down what truly separates implant systems today (hint: it's not just the implant), including support, protocol, simplicity, and predictable workflows. Joe also shares how NeoBiotech approaches anytime loading concepts, restorative solutions, repair kits, stability testing, and digitally guided workflows designed to reduce guesswork and save chair time. If you're placing implants (or thinking about starting) and want a system built around clinical confidence + real support, this episode is for you.

The use of saunas is exploding in popularity in the US, but they've been a standard part of life in other parts of the world. Finland is the best example, with more than one sauna for every 2 people! What is it about the health, wellbeing and high performance benefits that are driving such engagement? Is it a fad? Or is the trend driven by dependable evidence? What frequency, duration and temperature are recommended for better health & wellbeing? How about for athletic performance? What's the difference between infrared and traditional saunas? Today's guest, Dr. Daniel Gagnon is a thermal physiologist who has been studying the effects of heat exposure on human health & performance for over 2 decades! He is an associate professor at the University of Montreal and researcher at the Montreal Health Institute. If you've been curious about what the evidence is saying about saunas, you've come to the right place.Here are the two studies Dr. Gagnon mentioned during the discussion: Meta-analysis 1Meta-analysis 2Info re earning your health & wellness coaching certification, annual Rocky Mountain Coaching Retreat & Symposium & more via https://www.catalystcoachinginstitute.com/ Best-in-class coaching for Employers, EAPs & wellness providers https://catalystcoaching360.com/ Tap into the home of the (freely available) Not Done Yet! articles on unlocking life's 2nd half here. YouTube Coaching Channel https://www.youtube.com/c/CoachingChannel Contact us: Results@CatalystCoaching360.comTwitter: @Catalyst2ThriveWebsite: CatalystCoaching360.comIf you are a current or future health & wellness coach, please check out our Health & Wellness Coaching Community on Facebook: https://www.facebook.com/groups/278207545599218. This is a wonderful group if you are looking for encouragement, ideas, resources and more.

Today at our Pittsburgh UFO Meeting we pay homage to our fallen friend, the legendary Fred SalugaFred Saluga Bio -Fred Saluga has been investigating Bigfoot, UFOs, and other paranormal phenomena for over 50 years. He is a licensed private investigator in the States of West Virginia, Florida, and Pennsylvania and a retired law enforcement officer and Chief of Police in Fayette County, PA. He currently serves as the State Director for the Mutual UFO Network (MUFON) in WV and the Assistant State Director of MUFON in PA. Fred has investigated over 500 UFO cases and established MUFON's Humanoid Research Group, which oversees the investigation of humanoid beings reported as UFO occupants.He was the co-host of a Comcast Presentation that lasted for three years and produced television shows called “UFOs Over Pittsburgh” and now a podcast called “String Theory (40 movies) on YouTube.He is also served as the Director of the West Virginia Center for Unexplained Events, an organization dedicated to investigating sightings of Bigfoot, cryptids, ghosts, and other anomalous entities. He is the Director of the Fayette County, PA Bigfoot Research Project, headquartered in Uniontown, PA.Note from Mufon Director on Fred:MUFON West Virginia State Dir. and PA ASD Fred Saluga passed away. Fred joined MUFON in Florida in 1996 and worked with Joe Jordan. In 2007, I noticed Fred's name on our member list with a Florida address. I quickly recruited him into PA MUFON. When the 2008 Bucks County UFO Wave hit, our cases tripled. With the broadcast of Discovery Channels UFOs over Earth, our membership and investigators also tripled. With managing 7 states, Fred and Bill Weber were integral in helping me run PA-WV-DEL MUFON. I promoted Fred to WV SD and Bill to DEL SD, but we always worked as a team conducting training classes and 42 conferences in Erie, Pittsburgh, and Philly from 2008-2024. Fred was the people's skills, and I was the manager's skills. Fred and I did a monthly show on public TV called UFOs over Pittsburgh. After 44 episodes, we moved the show to my house under the name of String Theory of the Unexplained. In total, we did almost 100 episodes and they are available on YouTube. We made PA MUFON great!Fred was a character. He would refer to his hometown as Fayettenam so I would introduce Fred as the James Bond of Fayettenam. His passion for Bigfoot far exceeded his passion for UFOs. We lobbied MUFON to investigate the Bigfoot-UFO connection. Fred would conduct free UFO-Bigfoot conferences in extended rural locations to get the word out. Fred taught a UFO class at a local college which I have picked up as instructor. Fred, Bill, John Dousette, and I went to many Symposiums together. The most fun was in Vegas, of course, when we stayed on the Strip at my timeshare. Fred was a good friend and will be missed by many, especially me. I will miss our long drives around the state and our talks on conservative politics, UFOs, and cryptids. . . .From his daughter Leah prior to his passing, “My father is truly one of a kind. At 76, he's lived a life defined by selflessness, honesty, and a deep commitment to helping others. Even now, after being diagnosed with acute myeloid leukemia, he continues to inspire everyone around him with his strength and wit. He's been a Police Chief, CYF investigator, outpatient drug and alcohol counselor, Bigfoot and paranormal investigator. His curiosity and compassion have touched countless lives; he's always been there for people-no matter who they are or what they are going through. Throughout his life, my father has made a huge difference in this world and in so many people's lives. His impact goes far beyond our family-he's been a friend, mentor, and source of hope for so many. This diagnosis has forced him to stop working and relocate to Pittsburgh for treatment, far from his home in West Virginia. Now the time has come that his body is not responding to the treatments, one treatment affects another in not so good ways. So what it is now is the end of the road for my Poppa. He's going to be crossing the rainbow bridge anytime now. Comfort measures only at this time. I do want to also say how very strong and courageous he is through all of this up until he just fell asleep, we were still talking, and laughing, and still handling business. I want to complete his end of life wishes. I want to celebrate his life, to remember all the memories with him. Those cherished moments I'll hold in my heart forever each one unwrapping a smile. I know that he was loved by many and that's because he loved so many. Thanks in advance”. Leah SalugaTypical Skeptic Podcast Links and Affiliates:Support the Mission:

Doug Reynolds is the founder and guiding force behind Low Carb USA, a leading global organization championing evidence-based low-carb and ketogenic nutrition. A former engineer turned health advocate, Doug launched Low Carb USA after his own dramatic health transformation, channeling his passion into creating world-class conferences, practitioner training, and a thriving community dedicated to metabolic health. Today, he's recognized as a pivotal connector in the low-carb movement—bringing researchers, clinicians, and everyday people together to rethink chronic disease and reclaim their health. In this episode, Dr. Tro and Doug talk about… (00:00) Intro (01:02) The upcoming Symposium for Metabolic Health in Boca Raton, Florida (03:44) Doug's personal health story and why he founded Low Carb USA (08:40) The SMHP and the history of Low Carb USA conferences (19:38) Why cardiovascular health is the main focus of the Boca Raton Symposium in 2026 (21:48) The exciting lineup of powerhouse speakers for the upcoming Boca Symposium (30:25) Low Carb Denver and other SMHP/Low Carb USA conferences (36:28) Why you should care about metabolic health and come to the upcoming Symposium (links below) For more information, please see the links below. Thank you for listening! Links: Please consider supporting us on Patreon: https://www.lowcarbmd.com/ Doug Reynolds: Symposium for Metabolic Health: https://www.lowcarbusa.org/boca-2026/#about Low Carb USA: https://www.lowcarbusa.org Society of Metabolic Health Practitioners: https://thesmhp.org X: https://x.com/DougieReynolds Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro IG: https://www.instagram.com/doctortro/ Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.  Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/